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Background: This study aimed to evaluate the potential relation of attenuated-signal
plaque (ASP) and calciﬁed plaque (CP) observed by IVUS, and its impact on neo-
intimal hyperplasia after DES implantation.
Methods: Serial (baseline and 8-9 months) IVUS was performed in 642 lesions
treated with DES: 139 paclitaxel- (PES), 240 Endeavor zotarolimus- (E-ZES), 122
Resolute zotarolimus- (R-ZES), and 141 everolimus-eluting stents (EES). ASP was
deﬁned as hypo- or isoechoic plaque with ultrasound attenuation without calciﬁcation.
CP was deﬁned as brightly echoreﬂective plaque with acoustic shadowing. ASP and
CP scores were calculated by grading their measured angle from 0 to 4 (for 0, < 90,
90-180, 180-270 and >270, respectively) for the entire stented segment analyzed at
1-mm intervals (Figure A).
Results: Overall, ASP was observed in 45% of lesions at baseline, and this group had
larger % neointimal volume (%NIV) at follow-up than no-ASP group (p< 0.001).
During follow-up, ASP group showed decrease in ASP score and increase in CP score
with a signiﬁcant inverse correlation between the 2 scores (r¼-0.486). When ASP
group was classiﬁed as “transformed” or “persistent” ASP using the median of score
change, %NIV was signiﬁcantly higher in persistent ASP group than no-ASP and
transformed ASP groups (Figure B). This result was observed signiﬁcantly in PES and
E-ZES, modestly in R-ZES, but not in EES.
Conclusions: Persistent ASP was associated with accelerated neointimal proliferation
across the various DES. Transformation of ASP into CP during follow-up may
represent the stabilization process of the underlying plaque.TCT-351
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Background: IVUS studies of atherosclerotic coronary disease have shown that
attenuated-signal plaque (ASP) is associated with plaque instability (inﬂammatory
plaque). However, it is unknown whether this applies to cardiac allograft vasculopathy
(CAV) in heart transplant recipients.
Methods: In 67 patients, baseline (4-6 weeks post-transplant) and 1-year volumetric
IVUS was performed in the ﬁrst 50 mm of the left anterior descending artery. ASP
was identiﬁed as hypo/iso-echoic plaque with signal attenuation but without calciﬁ-
cation. ASP score was calculated by grading the measured angle of attenuation from
0 to 4 (for 0, < 90, 90-180, 180-270 and >270) at 1-mm intervals. Acute
cellular rejection was deﬁned by endomyocardial biopsy as ISHLT Grade 2R.
Results: At baseline, ASP was seen in 16.4% of patients. At 1 year, changes in
intimal, vessel, and lumen volumes did not differ in patients with or without ASP at
baseline. On the other hand, 10.5% of the enrolled patients showed ASP progression
(newly developed or increased ASP score) during follow-up, associated with a
greater increase in intimal volume with greater lumen loss than no ASP progression
patients (Figure). The incidence of acute cellular rejection (1 episode) during
follow-up was signiﬁcantly higher in patients with ASP progression (86% vs. 18%,
p< 0.01).
Conclusions: Development and progression of attenuated-signal plaque after heart
transplantation may reﬂect chronic inﬂammation related to acute cellular rejection and
is associated with progression of CAV. The prognostic value of this IVUS ﬁnding
awaits longer-term patient follow-up.B102 JACC Vol 64/11/Suppl B jTCT-352
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Background: A novel high-deﬁnition IVUS system (ACIST Medical Systems, Inc.)
with a 60MHz mechanical catheter offers rapid image acquisition at 60 fps,
allowing signiﬁcantly faster automated pullback than conventional IVUS systems.
Technically, however, a frame pitch of cross-sections obtained at 10 mm/sec is
10 times larger (167 mm) compared with 0.5 mm/sec pullback with conventional
mechanical IVUS systems. This study aimed to evaluate the feasibility and accuracy
of the high speed pullback in quantitative and qualitative assessment of coronary
arteries.
Methods: High speed pullback images at 10 mm/sec were evaluated in 7 human
autopsied coronary specimens under pressured bolus saline ﬂush. Lumen and vessel
areas in matched cross-sections, side branches, and the distance between ﬁducial
landmarks were compared with those obtained with 0.5 mm/sec pullback.
Results: Lumen and vessel areas (n¼46) showed good agreement between 10 mm/sec
and 0.5 mm/sec (R2¼0.941 P< 0.0001, R2¼0.970 P< 0.0001, respectively). Side
branches including minor branches (< 0.5mm diameter) found in 0.5 mm/sec
pullback (n¼21) were all detected in 10 mm/sec pullback imaging. The longitudinal
distances between each landmark (n¼47) also showed good correlation (R2¼0.993,
P< 0.0001).Conclusions: High speed pullback of a novel high-deﬁnition IVUS system allowed
comparable quantitative and qualitative assessment of coronary arteries compared
with conventional 0.5 mm/sec pullback. This technology may facilitate rapid
assessment of the coronary artery as well as high contrast IVUS imaging with bolus
contrast/saline ﬂush during the pullback.September 13–17, 2014 j TCT Abstracts/Imaging Intravascular - IVUS
